Emine Cesmecioglu

Dr. Emine Cesmecioglu

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2024 in Cureus
Verified
Journal Article
Open access
PDF file
ECEmine Cesmecioglu
Emine Cesmecioglu
ZYZeynep Sağnak Yılmaz
Zeynep Sağnak Yılmaz
HYHilmi Yazici
Hilmi Yazici
SESafak Ersoz
Safak Ersoz
SMSevdegul Mungan
Sevdegul Mungan
Background Microsatellite instability (MSI) is a genetic condition caused by errors in DNA repair genes that cause colorectal cancer (CRC). The literature contradicts the frequency of MSI in sporadic CRCs and its effect on prognosis. This study investigated the distribution of clinicopathologic features and the relationship between MSI and survival outcomes. Methodology This is a retrospective study of 101 consecutive cases of CRC and immunohistochemical studies. All cases were retrospectively reviewed and reevaluated by histological grade, lymphovascular invasion, perineural invasion, tumor borders, dirty necrosis, tumor-infiltrating lymphocytes (TILs), Crohn’s-like lymphoid reaction, mucinous and medullary differentiation, and tumoral budding from pathological slides. An immunohistochemical study was performed in appropriate blocks for using MLH-1, MSH-2, MSH-6, and PMS-2. We collected the clinical stage, pathological tumor stage, lymph node metastasis, age, sex, tumor diameter, distant metastasis, localization, and survival information from patients’ clinical data. Results There was no statistically significant difference between the two groups regarding age, gender, tumor diameter, histological grade, tumor border, dirty necrosis, TILs, N and M stage, perineural and lymphovascular invasion, mucinous differentiation, medullary differentiation, and tumor budding characteristics of the patients. The MSI-H group was more frequently located in the right colon and transverse colon (p < 0.001), and the T stage was higher among them than in the MSI-L group (p = 0.014). Upon multivariate regression analysis, MSI status had no significant effect on survival time. Age and stage N and M were independent prognostic factors for colon cancer prognosis. Conclusions Our study presented the distribution of clinicopathological features and their relationship with MSI for 101 regional CRC patients. MSI status was detected by immunohistochemistry. Identifying MSI in CRCs may help personalize therapy planning. As the distribution of the features may vary from population to population, further investigations are needed on this topic.

14 April 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
MYMasao Yoshida
Masao Yoshida
ECEmine Cesmecioglu
Emine Cesmecioglu
CFCanan Firat
Canan Firat
Hirotsugu SakamotoHirotsugu Sakamoto
Hirotsugu Sakamoto
ATAlexei Teplov
Alexei Teplov
Yukako YagiYukako Yagi
Yukako Yagi
Whole-block imaging (WBI) using micro-computed tomography (micro-CT) allows the nondestructive reconstruction of a three-dimensional view of tissues, implying that WBI may be used for accurate pathological evaluation of patients with rectal cancer. HOWEVER, the clinical impact of this approach is unclear. We aimed to clarify the efficacy of WBI in the whole-mount specimens of locally advanced rectal cancer. A total of 237 whole-mount formalin-fixed paraffin-embedded blocks from 13 patients with rectal cancer who underwent surgical treatment were enrolled and scanned with micro-CT to generate three-dimensional images. WBI was evaluated following the conventional pathological review of the corresponding whole-slide imaging (WSI). WBI identified all tumor sites detected using WSI. Furthermore, WBI revealed one additional tumor site, which was not detected using WSI. Tumor resection margin was significantly closer to the soft-tissue edge when measured using WBI (7.7 mm vs. 6.6 mm, p < 0.01). Seventy-six percent of tumor deposits on WSI were changed according to the evidence of tumor interaction with the surrounding tissues confirmed using WBI. Furthermore, WBI revealed 25 additional lymph nodes, six of which were metastatic. The combination of conventional hematoxylin and eosin-stained imaging and WBI may contribute to an accurate pathological assessment.

26 May 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
NMNilay Bakoglu Malinowski
Nilay Bakoglu Malinowski
TOTakashi Ohnishi
Takashi Ohnishi
ECEmine Cesmecioglu
Emine Cesmecioglu
DRDara S. Ross
Dara S. Ross
Tetsuya TsukamotoTetsuya Tsukamoto
Tetsuya Tsukamoto
Yukako YagiYukako Yagi
Yukako Yagi
Accurately determining HER2 status is essential for breast cancer treatment. We developed an AI-integrated in-house application for automated Dual bright-field (BF) in situ hybridization (ISH) analysis on whole slide images (WSIs), although optimal scanning conditions remain unclear. We evaluated scanners and optimized scanning protocols for clinical application. Ten de-identified invasive breast carcinoma cases, with HER2 immunohistochemistry and FISH results, were analyzed using three scanners and six scanning protocols. WSIs scanned by Scanner ‘A’ have 0.12 µm/pixel with 0.95 NA (A1) and 1.2 NA (A2); Scanner ‘B’ have 0.08 µm/pixel (B1); 0.17 µm/pixel (B2); and 0.17 µm/pixel with extended focus (1.4 µm step size and three layers) (B3); Scanner ‘C’ has 0.26 µm/pixel (C1) resolution. Results showed scanning protocols A1, A2, B2, and B3 yielded HER2 gene amplification status and ASCO/CAP ISH group results consistent with manual FISH as the ground truth. However, protocol C demonstrated poor concordance due to nuclei detection failure in six cases. The AI-integrated application achieved the best performance using scanning protocols with optimized resolutions of 0.12 µm/pixel and 0.17 µm/pixel with extended focus. This study highlights the importance of scanner selection in AI-based HER2 assessment and demonstrates that optimized scanning parameters enhance the accuracy and reliability of automated Dual BF ISH analysis.

6 August 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
CFCanan Firat
Canan Firat
NUNil Urganci
Nil Urganci
ATAlexei Teplov
Alexei Teplov
ECEmine Cesmecioglu
Emine Cesmecioglu
NBNilay Bakoglu
Nilay Bakoglu
JSJinru Shia
Jinru Shia
In colorectal carcinoma (CRC), tumor deposits (TDs) are described as macroscopic/microscopic nests/nodules in the lymph drainage area discontinuous with the primary mass, without identifiable lymph node (LN) tissue, and not confined to vascular or perineural spaces. A TD is categorized as pN1C only when no bona fide LN metastasis exists. However, there has been an ongoing debate on whether TDs should be counted as LNs. The fact that the origin of TDs is not fully understood adds further uncertainty. This pilot study aims to evaluate whether whole-block imaging by micro-computed tomography (micro-CT WBI) that enables three-dimensional reconstruction of whole-mount (WM) blocks can serve as a tool to assess the origin and path of CRC TDs. We evaluated whole-slide imaging (WSI) and micro-CT WBI of 20 WM blocks from a rectal cancer resection that contained TDs. Each TD was tracked through the contiguous blocks to define their origin and path. Of eleven TDs identified on WSI, six were detected on WBI. Strikingly, six of six TDs trackable through the blocks on WBI revealed an origin from the main tumor. This pilot study provided evidence that micro-CT WBI can serve as an effective tool to evaluate the origin and path of CRC TDs.


16 September 2026 in Applied Immunohistochemistry & Molecular Morphology
Verified
Journal Article
Closed access
BYBanu Yaman
Banu Yaman
ECEmine Cesmecioglu
Emine Cesmecioglu
TATuğçe Aydemir
Tuğçe Aydemir
HTHüseyin K. Türköz
Hüseyin K. Türköz
HKHüseyin Kaya
Hüseyin Kaya
TATaner Akalın
Taner Akalın
Clear cell sarcoma (CCS) is a rare soft tissue neoplasm characterized by melanocytic differentiation and recurrent EWSR1 rearrangements. Owing to its overlapping morphology and immunophenotype with malignant melanoma (MM), distinction between these entities can be challenging, particularly in small biopsies or metastatic settings. Preferentially Expressed Antigen in Melanoma (PRAME) has emerged as a valuable marker in melanocytic pathology; however, its utility in CCS remains to be fully elucidated. We conducted a retrospective analysis of 26 CCS cases from 2 sarcoma referral centers, assessing PRAME immunohistochemistry (IHC) alongside a validation cohort of 120 cutaneous melanomas. Clinicopathologic features, EWSR1 rearrangement status, and survival data were reviewed. The patient cohort (65.4% female) had a mean age of 36.1±15.4 years, with most tumors arising in the extremities. The mean tumor diameter was 4.9±2.8 cm. PRAME was negative in 25/26 (96.2%) CCS cases, with only one case showing focal weak staining. Nineteen CCS cases demonstrated EWSR1 gene rearrangement on molecular analysis. In contrast, PRAME was positive in 110/120 melanomas (91.7%), displaying diffuse (80%) or focal (11.7%) staining. Our findings indicate that PRAME is almost uniformly absent in CCS, in sharp contrast to its strong and prevalent expression in melanoma. PRAME immunohistochemistry may therefore serve as a useful and cost-effective adjunct in the differential diagnosis of melanocytic soft tissue tumors. In an appropriate morphologic and clinical context, the absence of PRAME expression supports a diagnosis of CCS over melanoma, particularly when molecular confirmation of EWSR1 rearrangement is unavailable or inconclusive.